Explore the latest pharmaceutical research, new drug developments, and FDA approvals. Stay informed on the therapies transforming disease management, from cancer treatments to chronic disease medications.
August 2025 will be remembered as a watershed moment for the biotechnology industry, with over 20 companies announcing significant layoffs as the sector undergoes its
In a dramatic reversal that highlights the delicate balance of vaccine development, the FDA has suspended use of the world’s first chikungunya vaccine after recipients
The UK’s National Institute for Health and Care Excellence (NICE) has proposed the most significant overhaul of type 2 diabetes treatment in over a decade,
In a landmark decision that could transform treatment for hundreds of thousands of Americans, the FDA has approved Brinsupri (insmedpirdine) as the first-ever medication specifically
Korean biotech successfully launches on Korea Exchange with focus on once-monthly injectable treatments including Alzheimer’s candidate G2Gbio completed its public market debut on the Korea
Cancer therapeutics company extends MIRACLE trial footprint with $7.6M cash runway through Q4 2025 Moleculin Biotech reported $7.6 million in cash on hand, expected to
Revolutionary needle-free epinephrine achieves $15.7M quarterly revenue with accelerating market adoption ARS Pharmaceuticals delivered exceptional Q2 2025 results with $15.7 million in total revenue, including
Canadian biotech advances RESOLVE Phase 2b trial for gastrointestinal indications with topline data expected H2 2026 Eupraxia Pharmaceuticals announced Q2 results and achieved a significant
President Trump to discuss policies boosting domestic drug production and innovation investment The White House announced plans for President Trump to meet with pharmaceutical industry
Senior credit facility supports Afrezza pediatric launch, commercial expansion, and pipeline advancement MannKind Corporation secured up to $500 million in a senior credit facility from
